326 related articles for article (PubMed ID: 20190962)
1. The role of adenosine in Alzheimer's disease.
Rahman A
Curr Neuropharmacol; 2009 Sep; 7(3):207-16. PubMed ID: 20190962
[TBL] [Abstract][Full Text] [Related]
2. A
Merighi S; Borea PA; Varani K; Vincenzi F; Jacobson KA; Gessi S
Curr Med Chem; 2022; 29(24):4138-4151. PubMed ID: 34844537
[TBL] [Abstract][Full Text] [Related]
3. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
4. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease.
Cellai L; Carvalho K; Faivre E; Deleau A; Vieau D; Buée L; Blum D; Mériaux C; Gomez-Murcia V
Front Neurosci; 2018; 12():520. PubMed ID: 30123104
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiological Role and Medicinal Chemistry of A
Merighi S; Borea PA; Varani K; Vincenzi F; Travagli A; Nigro M; Pasquini S; Suresh RR; Kim SW; Volkow ND; Jacobson KA; Gessi S
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566035
[TBL] [Abstract][Full Text] [Related]
6. Adenosine receptor control of cognition in normal and disease.
Chen JF
Int Rev Neurobiol; 2014; 119():257-307. PubMed ID: 25175970
[TBL] [Abstract][Full Text] [Related]
7. Caffeine for Prevention of Alzheimer's Disease: Is the A
Merighi S; Travagli A; Nigro M; Pasquini S; Cappello M; Contri C; Varani K; Vincenzi F; Borea PA; Gessi S
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371547
[TBL] [Abstract][Full Text] [Related]
8. Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies.
Takahashi RN; Pamplona FA; Prediger RD
Front Biosci; 2008 Jan; 13():2614-32. PubMed ID: 17981738
[TBL] [Abstract][Full Text] [Related]
9. Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia.
Espinosa J; Rocha A; Nunes F; Costa MS; Schein V; Kazlauckas V; Kalinine E; Souza DO; Cunha RA; Porciúncula LO
J Alzheimers Dis; 2013; 34(2):509-18. PubMed ID: 23241554
[TBL] [Abstract][Full Text] [Related]
10. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline.
Cunha RA; Agostinho PM
J Alzheimers Dis; 2010; 20 Suppl 1():S95-116. PubMed ID: 20182043
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.
Cunha GM; Canas PM; Melo CS; Hockemeyer J; Müller CE; Oliveira CR; Cunha RA
Exp Neurol; 2008 Apr; 210(2):776-81. PubMed ID: 18191838
[TBL] [Abstract][Full Text] [Related]
12. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
Dall'Igna OP; Fett P; Gomes MW; Souza DO; Cunha RA; Lara DR
Exp Neurol; 2007 Jan; 203(1):241-5. PubMed ID: 17007839
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Effect of a Selective Adenosine A
Faivre E; Coelho JE; Zornbach K; Malik E; Baqi Y; Schneider M; Cellai L; Carvalho K; Sebda S; Figeac M; Eddarkaoui S; Caillierez R; Chern Y; Heneka M; Sergeant N; Müller CE; Halle A; Buée L; Lopes LV; Blum D
Front Mol Neurosci; 2018; 11():235. PubMed ID: 30050407
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes and Adenosine A
Lopes CR; Cunha RA; Agostinho P
Front Neurosci; 2021; 15():666710. PubMed ID: 34054416
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Structural Insight into Adenosine A
Karati D; Mukherjee S; Roy S
Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
[TBL] [Abstract][Full Text] [Related]
16. Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
Giunta S; Andriolo V; Castorina A
Int J Biochem Cell Biol; 2014 Sep; 54():122-36. PubMed ID: 25058312
[TBL] [Abstract][Full Text] [Related]
17. The role of adenosine A
Launay A; Nebie O; Vijaya Shankara J; Lebouvier T; Buée L; Faivre E; Blum D
Neuropharmacology; 2023 Mar; 226():109379. PubMed ID: 36572177
[TBL] [Abstract][Full Text] [Related]
18. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.
Rivera-Oliver M; Díaz-Ríos M
Life Sci; 2014 Apr; 101(1-2):1-9. PubMed ID: 24530739
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
Canas PM; Porciúncula LO; Cunha GM; Silva CG; Machado NJ; Oliveira JM; Oliveira CR; Cunha RA
J Neurosci; 2009 Nov; 29(47):14741-51. PubMed ID: 19940169
[TBL] [Abstract][Full Text] [Related]
20. Adenosine receptor signalling in Alzheimer's disease.
Trinh PNH; Baltos JA; Hellyer SD; May LT; Gregory KJ
Purinergic Signal; 2022 Sep; 18(3):359-381. PubMed ID: 35870032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
